10x Genomics, Inc. TXG Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s short- and long-term operating lease liabilities?
- 10x Genomics, Inc. (TXG) reported short- and long-term operating lease liabilities of -$2.85M in Q1 2026.
- How has 10x Genomics, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
- 10x Genomics, Inc.'s short- and long-term operating lease liabilities decreased by 8.5% year-over-year, from -$2.63M to -$2.85M.
- What is the long-term trend for 10x Genomics, Inc.'s short- and long-term operating lease liabilities?
- Over 3 years (2022 to 2025), 10x Genomics, Inc.'s short- and long-term operating lease liabilities has grown at a 17.1% compound annual growth rate (CAGR), from -$6.42M to -$10.31M.